Skip to main content
. 2011 Nov 3;2(11):e225. doi: 10.1038/cddis.2011.106

Figure 1.

Figure 1

Primary MCL cells and cell lines respond differently to WIN55,212-2 treatment. Primary MCL cells (a) and MCL cell lines (b) were treated with WIN55,212-2. Cell viability was assessed by PI staining at 48 h; the WIN55,212-2 concentration at which cell viability reaches 50% (IC50 values) are based on a four-parameter iterative fitting; (c) XTT assay (n=3 × 3) of MCL cell lines: Granta519, Rec1, JeKo and JVM2 treated with WIN55,212-2 for 48 h